ArticleNPJ vaccines2024
A Phase 1 randomized trial of homologous and heterologous filovirus vaccines with a late booster dose.
Christina A Rostad et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it